Sectors
GOSS
Gossamer Bio, Inc.
0.17
8 x 0.15
2 x 0.18
bid
ask
-
0.00
0.06%
5 @ 07:59 PM
0.17 +0.00 (0.47%)
| Ytd | -94.52% | |
| 1y | -93.12% |
0.17
day range
0.18
0.11
52 week range
3.87
| Open | 0.17 | Prev Close | 0.17 | Low | 0.17 | High | 0.18 | Mkt Cap | 83.10M |
| Vol | 10.15M | Avg Vol | 28.06M | EPS | -0.66 | P/E | N/A | Forward P/E | -1.24 |
| Beta | 1.96 | Short Ratio | 6.29 | Inst. Own | 77.48% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-04 | 50-d Avg | 0.17 | 200-d Avg | 1.17 | 1yr Est | 7.61 |
| Income Statement | |||
| Total Revenue | 9.24M | ||
| Revenues (USD) | 9.24M | ||
| Gross Profit | 9.24M | ||
| Operating Expenses | 35.31M | ||
| Research and Development Expense | 26.41M | ||
| Selling, General and Administrative Expense | 8.90M | ||
| Operating Income | -26.07M | ||
| Interest Expense | 2.71M | ||
| Net Income | 16.90M | ||
| Net Income Common Stock | 16.90M | ||
| Net Income Common Stock (USD) | 16.90M | ||
| Consolidated Income | 16.90M | ||
| Earnings per Basic Share | 0.05 | ||
| Earnings per Basic Share (USD) | 0.05 | ||
| Earnings per Diluted Share | -0.08 | ||
| Earning Before Interest & Taxes (EBIT) | 19.61M | ||
| Earning Before Interest & Taxes (USD) | 19.61M | ||
| Weighted Average Shares | 320.01M | ||
| Weighted Average Shares Diluted | 328.78M | ||
| Balance Sheet | |||
| Cash and Equivalents | 41.15M | ||
| Cash and Equivalents (USD) | 41.15M | ||
| Investments | 15.88M | ||
| Investments Current | 15.88M | ||
| Trade and Non-Trade Receivables | 6.11M | ||
| Current Assets | 72.72M | ||
| Property, Plant & Equipment Net | 3.71M | ||
| Total Assets | 76.87M | ||
| Debt Current | 36.15M | ||
| Total Debt | 39.10M | ||
| Current Liabilities | 137.78M | ||
| Debt Non-Current | 2.96M | ||
| Total Liabilities | 170.90M | ||
| Accumulated Retained Earnings (Deficit) | -1.47B | ||
| Accumulated Other Comprehensive Income | -3.73M | ||
| Shareholders Equity | -94.03M | ||
| Shareholders Equity (USD) | -94.03M | ||
| Assets Non-Current | 4.14M | ||
| Total Debt (USD) | 39.10M | ||
| Deferred Revenue | 37.22M | ||
| Liabilities Non-Current | 33.11M | ||
| Trade and Non-Trade Payables | 5.95M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 252.00K | ||
| Net Cash Flow from Financing | -3.14M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 120.00K | ||
| Issuance (Repayment) of Debt Securities | -1.96M | ||
| Net Cash Flow from Investing | 42.70M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 42.70M | ||
| Net Cash Flow from Operations | -39.42M | ||
| Effect of Exchange Rate Changes on Cash | -12.00K | ||
| Share Based Compensation | 2.46M | ||